Abstract | PURPOSE: MATERIALS AND METHODS: We conducted a retrospective review in adult patients on ECMO. Patients were included if they received ECMO for at least 5 days and concomitant UFH. RESULTS: There were 119 patients who met inclusion criteria. Twenty-three patients (19%) had a heparin- platelet factor 4 immunoassay performed. Patients with suspected HIT had a significantly lower platelet count within the first 3 days of ECMO, 69×10(9)/L (22-126×10(9)/L) vs 87.5×10(9)/L (63-149×10(9)/L); P=.04. The lowest platelet count on the day of HIT testing was 43×10(9)/L (26-73), representing a 71% reduction from baseline. Twenty patients (87%) had an optical density score less than 0.4, and all patients had a score less than 1.0. A functional assay was performed in 7 patients (30%), with only 1 patient having laboratory-confirmed HIT. CONCLUSIONS: The evaluation of HIT occurred in a small percentage of patients, with HIT rarely being detected. Patients who had heparin- platelet factor 4 immunoassay testing exhibited lower platelet counts with a similar duration of ECMO and UFH exposure.
|
Authors | Daryl Glick, Amy L Dzierba, Darryl Abrams, Justin Muir, Andrew Eisenberger, David Diuguid, Erik Abel, Cara Agerstrand, Matthew Bacchetta, Daniel Brodie |
Journal | Journal of critical care
(J Crit Care)
Vol. 30
Issue 6
Pg. 1190-4
(Dec 2015)
ISSN: 1557-8615 [Electronic] United States |
PMID | 26363901
(Publication Type: Journal Article)
|
Copyright | Copyright © 2015 Elsevier Inc. All rights reserved. |
Chemical References |
|
Topics |
- Adult
- Aged
- Anticoagulants
(adverse effects)
- Blood Coagulation
- Critical Care
- Extracorporeal Membrane Oxygenation
(adverse effects)
- Female
- Heparin
(adverse effects, chemistry)
- Hospitalization
- Humans
- Immunoassay
(methods)
- Intensive Care Units
- Length of Stay
- Male
- Middle Aged
- Retrospective Studies
- Thrombocytopenia
(chemically induced)
|